Skip to main content

Advertisement

SpringerLink
Log in

Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis

  • Research
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

This study conducts a systematic bibliometric analysis of tongue cancer publications to identify key topics, hotspots, and research distribution.

Methods

We analyzed tongue cancer publications in the Web of Science core collection database, assessing their quantity and quality. We investigated contributors, including countries, affiliations, journals, authors, and categories, within collaborative networks. Additionally, we synthesized key research findings using various analytical techniques, such as alluvial flow, burstness analysis, cluster analysis, co-occurrence network of associations, and network layer overlay.

Results

From 2000 to 2022, this bibliometric study covers 2205 articles and reviews across 617 journals, involving 72 countries, 2233 institutions, and 11,266 authors. It shows consistent growth, particularly in 2016. Key contributors include China (499 publications), Karolinska Institute (84 publications), Oral Oncology (144 publications), and Tuula Salo (47 publications). Other notable contributors are the USA (16,747 citations), the National Cancer Institute (NCI) (2597 citations), and the Memorial Sloan-Kettering Cancer Center (MSK) (2231 citations). Additionally, there are significant teams led by Tuula Salo and Dalianis. We have identified six primary clusters: #0 apoptosis, #1 depth of invasion, #2 radiotherapy, #3 hpv, #4 tongue cancer, #5 oral cancer. The top ten highly cited documents primarily pertain to epidemiology, prognostic indicators in early-stage oral tongue cancer, and HPV. Additionally, we observed 16 reference clusters, with depth of invasion (#3), young patients (#4), and tumor budding (#6) gaining prominence since 2012, indicating sustained research interests.

Conclusions

This analysis emphasizes the increasing scholarly interest in tongue cancer research. The bibliometric evaluation highlights pivotal recent research themes such as HPV, depth of invasion, tumor budding, and surgical margins.

Clinical relevance

The bibliometric analysis highlights the key topics and studies which have shaped the understanding and management of tongue cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yosefof E, Hilly O, Stern S, Bachar G, Shpitzer T, Mizrachi A (2020) Squamous cell carcinoma of the oral tongue: distinct epidemiological profile disease. Head Neck 42:2316–2320. https://doi.org/10.1002/hed.26177

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA: Cancer J Clin 72:7–33. https://doi.org/10.3322/caac.21708

    Article  PubMed  Google Scholar 

  3. Almangush A, Bello IO, Heikkinen I, Hagström J, Haglund C, Kowalski LP, Nieminen P, Coletta RD, Mäkitie AA, Salo T, Leivo I (2021) Stromal categorization in early oral tongue cancer. Virchows Archiv : Int J Pathol 478:925–932. https://doi.org/10.1007/s00428-020-02930-5

    Article  CAS  Google Scholar 

  4. Stepan KO, Mazul AL, Larson J, Shah P, Jackson RS, Pipkorn P, Kang SY, Puram SV (2023) Changing epidemiology of oral cavity cancer in the United States. Otolaryngolo-Head Neck Surg 168:761–768. https://doi.org/10.1177/01945998221098011

    Article  Google Scholar 

  5. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, Munck-Wikland E (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620–2623. https://doi.org/10.1002/ijc.22177

    Article  CAS  PubMed  Google Scholar 

  6. Hammarstedt L, Dahlstrand H, Lindquist D, Onelöv L, Ryott M, Luo J, Dalianis T, Ye W, Munck-Wikland E (2007) The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127:988–992. https://doi.org/10.1080/00016480601110170

    Article  PubMed  Google Scholar 

  7. Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110:1429–1435. https://doi.org/10.1002/cncr.22963

    Article  PubMed  Google Scholar 

  8. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol : Off J Am Soc Clin Oncol 26:612–619. https://doi.org/10.1200/jco.2007.14.1713

    Article  Google Scholar 

  9. Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362–366. https://doi.org/10.1002/ijc.24339

    Article  CAS  PubMed  Google Scholar 

  10. Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126:2879–2884. https://doi.org/10.1002/ijc.24994

    Article  CAS  PubMed  Google Scholar 

  11. Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789. https://doi.org/10.1016/s1470-2045(10)70017-6

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ramqvist T, Dalianis T (2010) Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 16:1671–1677. https://doi.org/10.3201/eid1611.100452

    Article  PubMed  PubMed Central  Google Scholar 

  13. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol : Off J Am Soc Clin Oncol 29:4294–4301. https://doi.org/10.1200/jco.2011.36.4596

    Article  Google Scholar 

  14. Bigcas JLM, Okuyemi OT (2023) Glossectomy. StatPearls Publishing, Book title

    Google Scholar 

  15. Copyright © 2023, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Oluwafunmilola Okuyemi declares no relevant financial relationships with ineligible companies.

  16. Deva FAL, Kalsotra G, Kalsotra P, Saraf A (2023) Tissue transfer after tongue resection: micro-vascular reconstruction using radial artery free flap versus reconstruction by split thickness skin graft in T2 lesions of tongue carcinoma. Indian J Otolaryngol Head Neck Surg : Off Publ Assoc Otolaryngol India 75:529–539. https://doi.org/10.1007/s12070-022-03380-y

    Article  Google Scholar 

  17. Huang CC, Yang TL, Tseng WH, Lee TC, Ko JY (2022) An alternative surgical technique for advanced tongue/tongue base cancer without free flap reconstruction. J Formos Med Assoc Taiwan yi zhi 121:2626–2632. https://doi.org/10.1016/j.jfma.2022.07.007

    Article  PubMed  Google Scholar 

  18. Brudasca I, Philouze P, Morinière S, Lallemant B, Vergez S, Malard O, Roux PE, Rossello N, Payen C and Céruse P (2023) Transoral Laser microsurgery versus robot-assisted surgery for squamous cell carcinoma of the tongue base (oncological and functional results)-a retrospective GETTEC multicenter study. Journal of clinical medicine 12. https://doi.org/10.3390/jcm12134210

  19. Jozkowiak M, Dyszkiewicz-Konwinska M, Ramlau P, Kranc W, Spaczynska J, Wierzchowski M, Kaczmarek M, Jodynis-Liebert J and Piotrowska-Kempisty H (2021) Individual and combined treatments with methylated resveratrol analogue DMU-214 and gefitinib inhibit tongue cancer cells growth via apoptosis induction and EGFR inhibition. International journal of molecular sciences 22. https://doi.org/10.3390/ijms22126180

  20. Zhan KY, Eskander A, Kang SY, Old MO, Ozer E, Agrawal AA, Carrau RL, Rocco JW, Teknos TN (2017) Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol 73:152–159. https://doi.org/10.1016/j.oraloncology.2017.08.020

    Article  PubMed  Google Scholar 

  21. Stern PL, Dalianis T (2021) Oropharyngeal squamous cell carcinoma treatment in the era of immune checkpoint inhibitors. Viruses 13(7):1234. https://doi.org/10.3390/v13071234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Maula AW, Fuad A, Utarini A (2018) Ten-years trend of dengue research in Indonesia and South-east Asian countries: a bibliometric analysis. Glob Health Action 11:1504398. https://doi.org/10.1080/16549716.2018.1504398

    Article  PubMed  PubMed Central  Google Scholar 

  23. Baskaran S, Agarwal A, Leisegang K, Pushparaj PN, Panner Selvam MK, Henkel R (2021) An in-depth bibliometric analysis and current perspective on male infertility research. World J Men’s Health 39:302–314. https://doi.org/10.5534/wjmh.180114

    Article  Google Scholar 

  24. Rondanelli M, Perna S, Peroni G, Guido D (2016) A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia. J Cosmet Dermatol 15:120–130. https://doi.org/10.1111/jocd.12198

    Article  PubMed  Google Scholar 

  25. Shen Z, Wu H, Chen Z, Hu J, Pan J, Kong J, Lin T (2022) The global research of artificial intelligence on prostate cancer: a 22-year bibliometric analysis. Front Oncol 12:843735. https://doi.org/10.3389/fonc.2022.843735

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ma C, Su H, Li H (2020) Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study. Front Oncol 10:627891. https://doi.org/10.3389/fonc.2020.627891

    Article  PubMed  Google Scholar 

  27. Ma D, Guan B, Song L, Liu Q, Fan Y, Zhao L, Wang T, Zhang Z, Gao Z, Li S, Xu H (2021) A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med 8:734514. https://doi.org/10.3389/fcvm.2021.734514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Huang L, Xu G, He J, Tian H, Zhou Z, Huang F, Liu Y, Sun M, Liang F (2021) Bibliometric analysis of functional magnetic resonance imaging studies on acupuncture analgesia over the past 20 years. J Pain Res 14:3773–3789. https://doi.org/10.2147/jpr.S340961

    Article  PubMed  PubMed Central  Google Scholar 

  29. D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529. https://doi.org/10.1056/NEJMoa1506007

    Article  CAS  PubMed  Google Scholar 

  30. Liang YD, Li Y, Zhao J, Wang XY, Zhu HZ, Chen XH (2017) Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res 10:951–964. https://doi.org/10.2147/jpr.S132808

    Article  PubMed  PubMed Central  Google Scholar 

  31. Baba A, Hashimoto K, Kayama R, Yamauchi H, Ikeda K, Hiroya O (2021) to: Radiological approach for the newly incorporated T staging factor, depth of invasion(DOI), of the oral tongue cancer in the 8th edition of American Joint Committee on Cancer (AJCC) staging manual: assessment of the necessity for elective neck dissection. Jpn J Radiol 39:100

    Article  PubMed  Google Scholar 

  32. Mao MH, Wang S, Feng ZE, Li JZ, Li H, Qin LZ, Han ZX (2019) Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. Prospect Cohort Stud Oral Oncol 91:79–84. https://doi.org/10.1016/j.oraloncology.2019.01.021

    Article  Google Scholar 

  33. Murakami R, Shiraishi S, Yoshida R, Sakata J, Yamana K, Hirosue A, Uchiyama Y, Nakayama H, Yamashita Y (2019) Reliability of MRI-derived depth of invasion of oral tongue cancer. Acad Radiol 26:e180–e186. https://doi.org/10.1016/j.acra.2018.08.021

    Article  PubMed  Google Scholar 

  34. Melchers LJ, Schuuring E, van Dijk BA, de Bock GH, Witjes MJ, van der Laan BF, van der Wal JE, Roodenburg JL (2012) Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 48:337–342. https://doi.org/10.1016/j.oraloncology.2011.11.007

    Article  CAS  PubMed  Google Scholar 

  35. Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Takita M, Mitsunaga S, Mizoguchi N, Nonaka T, Nakayama Y, Oridate N (2017) Predictive significance of tumor depth and budding for late lymph node metastases in patients with clinical N0 early oral tongue carcinoma. Head Neck Pathol 11:477–486. https://doi.org/10.1007/s12105-017-0814-1

    Article  PubMed  PubMed Central  Google Scholar 

  36. Marangon Junior H, Rocha VN, Leite CF, de Aguiar MC, Souza PE, Horta MC (2014) Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma. J Pathol Med : Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 43:199–204. https://doi.org/10.1111/jop.12121

    Article  CAS  Google Scholar 

  37. Xie N, Wang C, Liu X, Li R, Hou J, Chen X, Huang H (2015) Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral pathol Med : Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 44:266–272. https://doi.org/10.1111/jop.12242

    Article  Google Scholar 

  38. Almangush A, Bello IO, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma VM, Koivunen P, Grénman R, Leivo I, Salo T (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36:811–818. https://doi.org/10.1002/hed.23380

    Article  PubMed  Google Scholar 

  39. Almangush A, Salo T, Hagström J, Leivo I (2014) Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology 65:587–594. https://doi.org/10.1111/his.12471

    Article  PubMed  Google Scholar 

  40. Hamada M, Ebihara Y, Nagata K, Yano M, Kogashiwa Y, Nakahira M, Sugasawa M, Nagatsuka H, Yasuda M (2020) Podoplanin is an efficient predictor of neck lymph node metastasis in tongue squamous cell carcinoma with low tumor budding grade. Oncol Lett 19:2602–2608. https://doi.org/10.3892/ol.2020.11358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Yamakawa N, Kirita T, Umeda M, Yanamoto S, Ota Y, Otsuru M, Okura M, Kurita H, Yamada SI, Hasegawa T, Aikawa T, Komori T, Ueda M (2019) Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma. J Surg Oncol 119:370–378. https://doi.org/10.1002/jso.25334

    Article  PubMed  Google Scholar 

  42. Nair D, Mair M, Singhvi H, Mishra A, Nair S, Agrawal J, Chaturvedi P (2018) Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment. Head Neck 40:1780–1787. https://doi.org/10.1002/hed.25170

    Article  PubMed  Google Scholar 

  43. Cassidy RJ, Switchenko JM, Jegadeesh N, Sayan M, Ferris MJ, Eaton BR, Higgins KA, Wadsworth JT, Magliocca KR, Saba NF, Beitler JJ (2017) Association of lymphovascular space invasion with locoregional failure and survival in patients with node-negative oral tongue cancers. JAMA Otolaryngol Head Neck Surg 143:382–388

    Article  PubMed  PubMed Central  Google Scholar 

  44. Alicandri-Ciufelli M, Bonali M, Piccinini A, Marra L, Ghidini A, Cunsolo EM, Maiorana A, Presutti L, Conte PF (2013) Surgical margins in head and neck squamous cell carcinoma: what is “close”? Eur Arch Oto-Rhino 270:2603–9. https://doi.org/10.1007/s00405-012-2317-8

    Article  Google Scholar 

  45. Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, Shah JP, Wong RJ, Ghossein RA, Patel SG (2017) A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue. JAMA Otolaryngol Neck Surg 143:555–560. https://doi.org/10.1001/jamaoto.2016.4238

    Article  Google Scholar 

  46. Singh A, Mishra A, Singhvi H, Sharin F, Bal M, Laskar SG, Prabhash K, Chaturvedi P (2020) Optimum surgical margins in squamous cell carcinoma of the oral tongue: Is the current definition adequate? Oral Oncol 111:104938. https://doi.org/10.1016/j.oraloncology.2020.104938

    Article  PubMed  Google Scholar 

  47. de Koning KJ, van Es RJJ, Klijn RJ, Breimer GE, Willem Dankbaar J, Braunius WW, van Cann EM, Dieleman FJ, Rijken JA, Tijink BM, de Bree R, Noorlag R (2022) Application and accuracy of ultrasound-guided resections of tongue cancer. Oral Oncol 133:106023. https://doi.org/10.1016/j.oraloncology.2022.106023

    Article  PubMed  Google Scholar 

  48. de Koning KJ, Koppes SA, de Bree R, Dankbaar JW, Willems SM, van Es RJJ, Noorlag R (2021) Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - comparison with conventional treatment. Oral Oncol 116:105249. https://doi.org/10.1016/j.oraloncology.2021.105249

    Article  PubMed  Google Scholar 

  49. Tarabichi O, Kanumuri V, Juliano AF, Faquin WC, Cunnane ME, Varvares MA (2018) Intraoperative ultrasound in oral tongue cancer resection: feasibility study and early outcomes. Otolaryngol-Head Neck Surg 158:645–648. https://doi.org/10.1177/0194599817742856

    Article  PubMed  Google Scholar 

  50. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720. https://doi.org/10.1093/jnci/92.9.709

    Article  CAS  PubMed  Google Scholar 

  51. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89:300–304

    Article  CAS  PubMed  Google Scholar 

  52. Lyon (2007) Monograph on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, France

    Google Scholar 

  53. Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2011) Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128:2892–2897. https://doi.org/10.1002/ijc.25625

    Article  CAS  PubMed  Google Scholar 

  54. Park S, Eom K, Kim J, Bang H, Wang HY, Ahn S, Kim G, Jang H, Kim S, Lee D, Park KH, Lee H (2017) MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer 17:658. https://doi.org/10.1186/s12885-017-3642-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Gołąbek K, Hudy D, Świętek A, Gaździcka J, Dąbrowska N, Miśkiewicz-Orczyk K, Zięba N, Misiołek M and Strzelczyk JK (2023) miR-125b-5p, miR-155–3p, and miR-214–5p and target E2F2 gene in oral squamous cell carcinoma. International journal of molecular sciences 24. https://doi.org/10.3390/ijms24076320

  56. Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ährlund-Richter A, Tertipis N, Munck-Wikland E, Näsman A, Ramqvist T, Dalianis T (2017) Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3. Oncotarget 8:35339–35350. https://doi.org/10.18632/oncotarget.15240

    Article  PubMed  PubMed Central  Google Scholar 

  57. Blank CU, Rozeman EA, Fanchi LF, Sikorska K, van de Wiel B, Kvistborg P, Krijgsman O, van den Braber M, Philips D, Broeks A, van Thienen JV, Mallo HA, Adriaansz S, Ter Meulen S, Pronk LM, Grijpink-Ongering LG, Bruining A, Gittelman RM, Warren S, van Tinteren H, Peeper DS, Haanen J, van Akkooi ACJ, Schumacher TN (2018) Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat Med 24:1655–1661. https://doi.org/10.1038/s41591-018-0198-0

    Article  CAS  PubMed  Google Scholar 

  58. Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch’ng S, Grijpink-Ongering LG, Stretch J, Heijmink S, van Tinteren H, Haanen J, Nieweg OE, Klop WMC, Zuur CL, Saw RPM, van Houdt WJ, Peeper DS, Spillane AJ, Hansson J, Schumacher TN, Long GV, Blank CU (2019) Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. Lancet Oncol 20:948–960. https://doi.org/10.1016/s1470-2045(19)30151-2

    Article  CAS  PubMed  Google Scholar 

  59. Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Lucianò R, Colecchia M, Giannatempo P, Mortarini R, Bianchi M, Farè E, Monopoli F, Colombo R, Gallina A, Salonia A, Messina A, Ali SM, Madison R, Ross JS, Chung JH, Salvioni R, Mariani L, Montorsi F (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol : Off J Am Soc Clin Oncol 36:3353–3360. https://doi.org/10.1200/jco.18.01148

    Article  CAS  Google Scholar 

  60. Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O’Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25:477–486. https://doi.org/10.1038/s41591-018-0337-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Schalper KA, Rodriguez-Ruiz ME, Diez-Valle R, López-Janeiro A, Porciuncula A, Idoate MA, Inogés S, de Andrea C, López-Diaz de Cerio A, Tejada S, Berraondo P, Villarroel-Espindola F, Choi J, Gúrpide A, Giraldez M, Goicoechea I, Gallego Perez-Larraya J, Sanmamed MF, Perez-Gracia JL, Melero I (2019) Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nat Med 25:470–476. https://doi.org/10.1038/s41591-018-0339-5

    Article  CAS  PubMed  Google Scholar 

  62. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet (London, England) 394:1915–1928. https://doi.org/10.1016/s0140-6736(19)32591-7

    Article  CAS  PubMed  Google Scholar 

  63. Zhang H, Yan J, Ren X, Sheng Y, Wang Z, Liang J, Yan Y, Jia Y, Li Z, Hou J (2022) Nimotuzumab combined with neoadjuvant or induction chemotherapy for head and neck squamous cell carcinoma: a retrospective study 24:707–716

    Google Scholar 

  64. Amin N, Maroun CA, El Asmar M, Alkhatib HH, Guller M, Herberg ME, Zhu G, Seiwert TY, Pardoll D, Eisele DW, Fakhry C, Gourin CG, Mandal R (2022) Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review. Head Neck 44:562–571. https://doi.org/10.1002/hed.26935

    Article  PubMed  Google Scholar 

  65. Shibata H, Saito S, Uppaluri R (2021) Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy. Front Oncol 11:727433. https://doi.org/10.3389/fonc.2021.727433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Schoenfeld JD, Hanna GJ, Jo VY, Rawal B, Chen YH, Catalano PS, Lako A, Ciantra Z, Weirather JL, Criscitiello S, Luoma A, Chau N, Lorch J, Kass JI, Annino D, Goguen L, Desai A, Ross B, Shah HJ, Jacene HA, Margalit DN, Tishler RB, Wucherpfennig KW, Rodig SJ, Uppaluri R, Haddad RI (2020) Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial. JAMA Oncol 6:1563–1570. https://doi.org/10.1001/jamaoncol.2020.2955

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Information and TCM Big Data Innovation Lab of Beijing Office of Academic Research and Department of Oncology and Department of Scientific Research, China Academy of Chinese Medical Science, Xiyuan Hospital, Beijing, 10091, China

    Beibei Wu, Tong Zhang, Ning Dai, Ding Luo, Xuejie Wang, Chen Qiao & Jian Liu

Authors
  1. Beibei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ning Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ding Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xuejie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chen Qiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BW and JL designed the study and wrote the manuscript. BW and CQ collected the data. DL and XW re-examined the data. BW, ND, and DL analyzed the data. JL and TZ reviewed and revised the manuscript. All authors contributed to the article and approved the submitted version.

Corresponding author

Correspondence to Jian Liu.

Ethics declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Consent to participate

For this type of study, formal consent is not required.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, B., Zhang, T., Dai, N. et al. Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis. Clin Oral Invest 28, 130 (2024). https://doi.org/10.1007/s00784-024-05516-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00784-024-05516-6

Keywords

Search

Navigation